XML 76 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Mar. 31, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
OPERATING ACTIVITIES              
Net income (loss) $ 53.8 $ 24.6 $ 15.9 $ 43.4 $ 154.8 $ 97.9  
Reconciliation to net cash provided by (used for) operating activities:              
Depreciation and amortization         75.3 76.1  
Equity in earnings of unconsolidated affiliate (3.8)   (5.9)   (13.9) (19.5)  
Costs related to legacy matters 3.7   74.6   52.1 78.8  
Cash paid for legacy matters         13.8 18.1  
Provision for (benefit from) income taxes 27.3   0.7   57.0 50.5  
Cash paid for income taxes         (39.6) (29.3)  
Income tax refunds received         7.1 0.3  
Loss on early extinguishment of debt 0.0   0.0   0.0 4.8  
Interest expense and related financing costs 18.6   20.4   58.2 59.6  
Cash paid for interest         (44.3) (46.3)  
Defined benefit pension expense         13.9 11.6  
Cash paid under defined benefit pension arrangements         (12.3) (61.8)  
Changes in assets and liabilities, excluding effect of currency translation and acquisitions:              
Trade accounts receivable         11.6 13.1  
Inventories         (58.0) (61.2)  
Accounts payable         13.6 17.6  
All other items, net         6.7 59.9  
Net cash provided by (used for) operating activities         268.4 234.0  
INVESTING ACTIVITIES              
Cash paid for capital expenditures         (142.6) (161.7)  
Business acquired, net of cash acquired         (22.8) (418.0)  
Other investing activities, net         (4.4) 13.8  
Net cash provided by (used for) investing activities         (169.8) (565.9)  
FINANCING ACTIVITIES              
Borrowings under credit arrangements         10.3 998.9  
Repayments under credit arrangements         (17.5) (558.5)  
Cash paid for debt financing costs         0.0 (11.8)  
Cash paid for repurchases of common stock         (29.8) (60.1)  
Proceeds from exercise of stock options         19.1 6.7  
Dividends paid to shareholders         (54.6) (48.5)  
Other financing activities, net         (4.9) (3.5)  
Net cash provided by (used for) financing activities         (77.4) 323.2  
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash         (3.3) (1.5)  
Net increase (decrease) in cash, cash equivalents, and restricted cash         17.9 (10.2)  
Cash, cash equivalents, and restricted cash, beginning of period   $ 201.0   $ 163.5 201.0 163.5 $ 163.5
Cash, cash equivalents, and restricted cash, end of period $ 218.9   $ 153.3   218.9 153.3 $ 201.0
Supplemental disclosure of cash flow information              
Capital expenditures in accounts payable         $ 39.4 $ 36.8